Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ligation-Driven Electrochemical Magneto-Genoassay Platform Based on PNA Probes for the Multiple Detection of Soy and Mustard DNA in Wheat Flour.

Biosensors·2026
Same author

Peptide Nucleic Acid Probes for MicroRNA Detection: Mg<sup>2+</sup> Ion Effect, Surface Hybridization, and Surface Plasmon Resonance Biosensing.

ACS measurement science au·2025
Same author

Safety of synthetic cannabidiol as a Novel food pursuant to Regulation (EU) 2015/2283.

EFSA journal. European Food Safety Authority·2025
Same author

High Affinity Dimeric Uracil-Based Receptor for the Recognition of Adenine Derivatives through Triplex-like Interactions.

The Journal of organic chemistry·2025
Same author

Point-of-Care Applicability of Graphene-Based Field Effect Transistors upon Modification with a Pyrene-Tagged Antifouling Copolymer: Application for cTnI Sensing in Blood.

ACS sensors·2025
Same author

Safety of lacto-N-tetraose (LNT) produced by a derivative strain (<i>Escherichia coli</i> K-12 MG1655 INB_LNT_01) of <i>E. coli</i> K-12 MG1655 (ATCC 700926) as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA journal. European Food Safety Authority·2025

Related Experiment Video

Updated: Jun 19, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Arginine-based PNA microarrays for APOE genotyping.

Alessandro Calabretta1, Tullia Tedeschi, Gabriella Di Cola

  • 1Department of Organic and Industrial Chemistry, University of Parma, Viale G.P. Usberti 17a, I-43100, Parma, Italy.

Molecular Biosystems
|October 14, 2009
PubMed
Summary

Researchers developed novel peptide nucleic acids (PNAs) for Alzheimer's disease genetic analysis. These modified PNAs demonstrate high specificity in recognizing single nucleotide polymorphisms (SNPs) within the APOE gene on a microarray platform.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Genetics

Background:

  • Alzheimer's disease (AD) is linked to specific genetic variations, particularly single nucleotide polymorphisms (SNPs) in the Apolipoprotein E (APOE) gene.
  • Accurate and specific genotyping for APOE SNPs is crucial for understanding AD risk and developing diagnostic tools.
  • Existing methods may lack the required specificity or efficiency for high-throughput genetic analysis.

Purpose of the Study:

  • To synthesize and characterize modified peptide nucleic acids (PNAs) with arginine-derived side chains for enhanced DNA binding.
  • To develop a PNA-based microarray platform for the specific detection of APOE gene SNPs associated with Alzheimer's disease.
  • To evaluate the diagnostic potential of the PNA microarray for APOE genotyping.

Main Methods:

  • Synthesis of four modified PNAs incorporating chiral monomers with arginine-derived side chains, designed for specific DNA hybridization.
  • In-solution testing of PNA binding affinity and specificity against complementary and mismatched DNA sequences using melting temperature analysis.
  • Development and optimization of PNA microarray fabrication, including probe deposition protocols to minimize cross-contamination.
  • Hybridization experiments on PNA microarrays using complementary, mismatched, and mixed oligonucleotide samples simulating APOE genotypes.

Main Results:

  • Modified PNAs exhibited high specificity in recognizing complementary DNA sequences and discriminating against mismatched sequences in solution.
  • Optimized PNA microarray platforms demonstrated excellent mismatch recognition capabilities.
  • Distinct hybridization patterns were observed for six different APOE genotypes, confirming the platform's high specificity and potential for genetic analysis.

Conclusions:

  • Arginine-based modified PNAs offer a promising tool for highly specific DNA binding and SNP recognition.
  • The developed PNA microarray platform provides a sensitive and specific method for APOE genotyping.
  • This approach holds significant potential for advancing diagnostic platforms for genetic diseases like Alzheimer's.